Single-isocenter multiple-target stereotactic radiosurgery for multiple brain metastases: dosimetric evaluation of two automated treatment planning systems

等中心 医学 放射外科 核医学 放射治疗计划 放射治疗 放射科
作者
G.H. Raza,Luca Capone,Paolo Tini,Martina Giraffa,Piercarlo Gentile,Giuseppe Minniti
出处
期刊:Radiation Oncology [BioMed Central]
卷期号:17 (1) 被引量:3
标识
DOI:10.1186/s13014-022-02086-3
摘要

Abstract Purpose Automated treatment planning systems are available for linear accelerator (linac)-based single-isocenter multi-target (SIMT) stereotactic radiosurgery (SRS) of brain metastases. In this study, we compared plan quality between Brainlab Elements Multiple Brain Metastases (Elements MBM) software which utilizes dynamic conformal arc therapy (DCAT) and Varian HyperArc (HA) software using a volumetric modulated arc therapy (VMAT) technique. Patients and methods Between July 2018 and April 2021, 36 consecutive patients ≥ 18 years old with 367 metastases who received SIMT SRS at UPMC Hillman Cancer San Pietro Hospital, Rome, were retrospectively evaluated. SRS plans were created using the commercial software Elements MBM SRS (Version 1.5 and 2.0). Median cumulative gross tumor volume (GTV) and planning tumor volume (PTV) were 1.33 cm 3 and 3.42 cm 3 , respectively. All patients were replanned using HA automated software. Extracted dosimetric parameters included mean dose (D mean ) to the healthy brain, volumes of the healthy brain receiving more than 5, 8,10, and 12 Gy (V 5Gy , V 8Gy , V 10Gy and V 12Gy ), and doses to hippocampi. Results Both techniques resulted in high-quality treatment plans, although Element MBM DCAT plans performed significantly better than HA VMAT plans, especially in cases of more than 10 lesions). Median V 12Gy was 13.6 (range, 1.87–45.9) cm 3 for DCAT plans and 18.5 (2.2–62,3) cm 3 for VMAT plans ( p < 0.0001), respectively. Similarly, V 10Gy , V 8Gy , V 5Gy ( p < 0.0001) and median dose to the normal brain ( p = 0.0001) were favorable for DCAT plans. Conclusions Both Elements MBM and HA systems were able to generate high-quality plans in patients with up to 25 brain metastases. DCAT plans performed better in terms of normal brain sparing, especially in patients with more than ten lesions and limited total tumor volume.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
赚钱的君发布了新的文献求助10
刚刚
刚刚
xiuxiuzhang发布了新的文献求助20
刚刚
刚刚
科研通AI6.4应助安然采纳,获得10
刚刚
科研通AI6.4应助安然采纳,获得10
刚刚
科研通AI6.4应助安然采纳,获得10
刚刚
科研通AI6.4应助安然采纳,获得10
1秒前
科研通AI6.3应助安然采纳,获得10
1秒前
科研通AI6.4应助安然采纳,获得10
1秒前
我是老大应助安然采纳,获得10
1秒前
科研通AI6.4应助安然采纳,获得10
1秒前
科研通AI6.2应助安然采纳,获得10
1秒前
科研通AI6.3应助斯文奇迹采纳,获得10
1秒前
1秒前
JamesPei应助朴素的凝云采纳,获得10
1秒前
柠木发布了新的文献求助10
2秒前
猪十六应助红烧茄子采纳,获得150
3秒前
无花果应助123采纳,获得10
4秒前
无花果应助儒雅的寄翠采纳,获得10
5秒前
nenoaowu发布了新的文献求助10
5秒前
orixero应助睡不醒的喵采纳,获得10
5秒前
ffbff发布了新的文献求助30
6秒前
科研通AI6.3应助安然采纳,获得30
8秒前
科研通AI6.2应助安然采纳,获得10
8秒前
科研通AI6.3应助安然采纳,获得10
8秒前
科研通AI6.4应助安然采纳,获得10
8秒前
科研通AI6.2应助安然采纳,获得10
8秒前
科研通AI6.2应助安然采纳,获得10
8秒前
科研通AI6.4应助安然采纳,获得30
8秒前
科研通AI6.3应助安然采纳,获得10
8秒前
科研通AI6.4应助安然采纳,获得10
9秒前
科研通AI6.3应助安然采纳,获得50
9秒前
9秒前
10秒前
11秒前
11秒前
红豆大王完成签到,获得积分10
11秒前
George完成签到,获得积分10
11秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
Resiliency Scale for Adolescents--Chinese Version 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
作者名:Kristopher P. Plain,悉尼大学的,目前只能查到其四篇论文,想找到其博士论文 550
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7328628
求助须知:如何正确求助?哪些是违规求助? 8943260
关于积分的说明 18969254
捐赠科研通 6984352
什么是DOI,文献DOI怎么找? 3216357
关于科研通互助平台的介绍 2383041
邀请新用户注册赠送积分活动 2195805